Article
WY14643 Increases Herpesvirus Replication Independently of PPARα Expression and Inhibits IFNβ Production
2021-11-02
Abstract excerpt
Peroxisome proliferator activated receptor (PPAR) agonists are commonly used to treat metabolic disorders in humans because they regulate fatty acid oxidation and cholesterol metabolism. In addition to their roles in controlling metabolism, PPAR agonists also regulate inflammation and are immunosuppressive in models of autoimmunity. We aimed to test whether activation of PPARα with clinically relevant ligands coul...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 0680a006-8a2b-59bc-a224-1128d67c811d
- DOI
- 10.1101/2021.10.29.466551
